Switch theme
Sign up to access all valuation multiples
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
1991
3.0K+
LTM Revenue $699M
LTM EBITDA -$97.3M
$1.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
OPKO Health has a last 12-month revenue of $699M and a last 12-month EBITDA of -$97.3M.
In the most recent fiscal year, OPKO Health achieved revenue of $713M and an EBITDA of $135M.
OPKO Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See OPKO Health valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $863M | $713M | XXX | XXX | XXX |
| Gross Profit | $288M | $318M | XXX | XXX | XXX |
| Gross Margin | 33% | 45% | XXX | XXX | XXX |
| EBITDA | -$65.5M | $135M | XXX | XXX | XXX |
| EBITDA Margin | -8% | 19% | XXX | XXX | XXX |
| Net Profit | -$328M | -$189M | XXX | XXX | XXX |
| Net Margin | -38% | -26% | XXX | XXX | XXX |
| Net Debt | $103M | $153M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, OPKO Health's stock price is $1.
OPKO Health has current market cap of $1.1B, and EV of $1.2B.
See OPKO Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.2B | $1.1B | XXX | XXX | XXX | XXX | $-0.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, OPKO Health has market cap of $1.1B and EV of $1.2B.
OPKO Health's trades at 1.7x LTM EV/Revenue multiple, and -12.3x LTM EBITDA.
Analysts estimate OPKO Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for OPKO Health and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.2B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 8.9x | XXX | XXX | XXX |
| P/E | -21.2x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -5.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpOPKO Health's NTM/LTM revenue growth is -3%
OPKO Health's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, OPKO Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate OPKO Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for OPKO Health and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -17% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -306% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 16% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 15% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 69% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
OPKO Health acquired XXX companies to date.
Last acquisition by OPKO Health was XXXXXXXX, XXXXX XXXXX XXXXXX . OPKO Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was OPKO Health founded? | OPKO Health was founded in 1991. |
| Where is OPKO Health headquartered? | OPKO Health is headquartered in United States of America. |
| How many employees does OPKO Health have? | As of today, OPKO Health has 3.0K+ employees. |
| Who is the CEO of OPKO Health? | OPKO Health's CEO is Dr. Phillip Frost, M.D.. |
| Is OPKO Health publicy listed? | Yes, OPKO Health is a public company listed on NAS. |
| What is the stock symbol of OPKO Health? | OPKO Health trades under OPK ticker. |
| When did OPKO Health go public? | OPKO Health went public in 1995. |
| Who are competitors of OPKO Health? | Similar companies to OPKO Health include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of OPKO Health? | OPKO Health's current market cap is $1.1B |
| What is the current revenue of OPKO Health? | OPKO Health's last 12-month revenue is $699M. |
| What is the current EBITDA of OPKO Health? | OPKO Health's last 12-month EBITDA is -$97.3M. |
| What is the current EV/Revenue multiple of OPKO Health? | Current revenue multiple of OPKO Health is 1.7x. |
| What is the current EV/EBITDA multiple of OPKO Health? | Current EBITDA multiple of OPKO Health is -12.3x. |
| What is the current revenue growth of OPKO Health? | OPKO Health revenue growth between 2023 and 2024 was -17%. |
| Is OPKO Health profitable? | Yes, OPKO Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
